METHODIST SUGAR LAND HOSPITAL — History
CCN 450820 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$680M
Latest Revenue (FY2022)
+15.2%
Revenue CAGR (3yr)
12.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $513M | $627M | $680M | +8.4% | +15.2% |
| Operating Expenses | $468M | $520M | $594M | +14.2% | +12.6% |
| Operating Margin | 8.6% | 17.1% | 12.6% | -26.3% | +20.9% |
| Net Income | $44M | $107M | $85M | -20.1% | +39.2% |
| Licensed Beds | 337 | 337 | 337 | +0.0% | +0.0% |
| Total Patient Days | 77,764 | 87,538 | 89,744 | +2.5% | +7.4% |
| Medicare Day % | 34% | 28% | 29% | +1.6% | -8.6% |
| Medicaid Day % | 8% | 7% | 8% | +1.3% | -1.9% |
COVID Impact & Recovery
Resilience Score: 73/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +32.6% ($513M → $680M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+15.2%
This Hospital
+7.6%
State Avg
Latest Margin
12.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $763M | 14.6% |
| FY2024 (proj) | $847M | 16.5% |
| FY2025 (proj) | $930M | 18.5% |